Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $28,900 | 18 | 86.2% |
| Food and Beverage | $3,034 | 129 | 9.1% |
| Travel and Lodging | $1,559 | 12 | 4.7% |
| Consulting Fee | $21.68 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan Inc. | $31,702 | 74 | $0 (2019) |
| ABBVIE INC. | $390.68 | 30 | $0 (2022) |
| Valeant Pharmaceuticals North America LLC | $282.23 | 8 | $0 (2017) |
| Torax Medical, Inc. | $154.06 | 1 | $0 (2017) |
| Amgen Inc. | $119.96 | 1 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $117.50 | 7 | $0 (2021) |
| Covidien LP | $105.40 | 1 | $0 (2017) |
| Ferring Pharmaceuticals Inc. | $83.69 | 5 | $0 (2020) |
| Braintree Laboratories, Inc. | $76.70 | 5 | $0 (2021) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $68.17 | 4 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $159.95 | 3 | Amgen Inc. ($119.96) |
| 2022 | $110.25 | 5 | Medtronic, Inc. ($53.99) |
| 2021 | $336.00 | 26 | AbbVie Inc. ($193.77) |
| 2020 | $163.90 | 10 | AbbVie Inc. ($69.27) |
| 2019 | $6,992 | 36 | Allergan Inc. ($6,775) |
| 2018 | $6,428 | 31 | Allergan Inc. ($6,278) |
| 2017 | $19,325 | 49 | Allergan Inc. ($18,649) |
All Payment Transactions
160 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/13/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | CYLTEZO (Drug) | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: CNS | ||||||
| 08/10/2023 | Amgen Inc. | AMJEVITA (Biological) | Food and Beverage | In-kind items and services | $119.96 | General |
| Category: Inflammation | ||||||
| 01/05/2023 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $22.55 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 03/10/2022 | Medtronic, Inc. | GI GENIUS (Device) | Food and Beverage | In-kind items and services | $23.89 | General |
| Category: Gastrointestinal AI | ||||||
| 03/02/2022 | Medtronic, Inc. | GI GENIUS (Device) | Food and Beverage | In-kind items and services | $30.10 | General |
| Category: Gastrointestinal AI | ||||||
| 02/22/2022 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $17.34 | General |
| Category: VIROLOGY | ||||||
| 02/07/2022 | Merck Sharp & Dohme LLC | DIFICID (Drug), ZINPLAVA | Food and Beverage | In-kind items and services | $20.29 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 01/25/2022 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $18.63 | General |
| Category: VIROLOGY | ||||||
| 12/20/2021 | AbbVie Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $4.54 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/14/2021 | AbbVie Inc. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $15.65 | General |
| Category: VIROLOGY | ||||||
| 11/09/2021 | Braintree Laboratories, Inc. | MOTOFEN (Drug), SUTAB | Food and Beverage | In-kind items and services | $20.53 | General |
| Category: GASTROENTEROLOGY - DIARRHEA | ||||||
| 10/21/2021 | AbbVie Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $3.85 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/12/2021 | AbbVie Inc. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $19.05 | General |
| Category: VIROLOGY | ||||||
| 09/27/2021 | Braintree Laboratories, Inc. | MOTOFEN (Drug), SUTAB | Food and Beverage | In-kind items and services | $13.89 | General |
| Category: GASTROENTEROLOGY - DIARRHEA | ||||||
| 09/09/2021 | AbbVie Inc. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $21.48 | General |
| Category: VIROLOGY | ||||||
| 08/05/2021 | AbbVie Inc. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $26.05 | General |
| Category: VIROLOGY | ||||||
| 08/02/2021 | Merck Sharp & Dohme Corporation | DIFICID (Drug), ZINPLAVA | Food and Beverage | In-kind items and services | $13.67 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 07/25/2021 | AbbVie Inc. | CREON (Drug) | Food and Beverage | In-kind items and services | $4.40 | General |
| Category: ENDOCRINOLOGY | ||||||
| 07/01/2021 | AbbVie Inc. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $15.91 | General |
| Category: VIROLOGY | ||||||
| 07/01/2021 | AbbVie Inc. | CREON (Drug) | Food and Beverage | In-kind items and services | $13.48 | General |
| Category: ENDOCRINOLOGY | ||||||
| 07/01/2021 | AbbVie Inc. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $0.91 | General |
| Category: VIROLOGY | ||||||
| 06/24/2021 | Takeda Pharmaceuticals U.S.A., Inc. | MOTEGRITY (Drug) | Food and Beverage | In-kind items and services | $24.90 | General |
| Category: INTERNAL MEDICINE | ||||||
| 05/18/2021 | Takeda Pharmaceuticals U.S.A., Inc. | MOTEGRITY (Drug) | Food and Beverage | In-kind items and services | $24.92 | General |
| Category: INTERNAL MEDICINE | ||||||
| 04/28/2021 | AbbVie Inc. | CREON (Drug) | Food and Beverage | In-kind items and services | $4.69 | General |
| Category: ENDOCRINOLOGY | ||||||
| 04/16/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.58 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 395 | 411 | $138,867 | $29,921 |
| 2022 | 10 | 691 | 738 | $252,474 | $56,351 |
| 2021 | 9 | 733 | 817 | $274,418 | $63,352 |
| 2020 | 9 | 660 | 729 | $224,945 | $49,939 |
All Medicare Procedures & Services
41 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 50 | 50 | $15,750 | $6,013 | 38.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 70 | 77 | $11,058 | $4,713 | 42.6% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 16 | 16 | $17,036 | $2,813 | 16.5% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 30 | 30 | $23,165 | $2,535 | 10.9% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 33 | 33 | $18,375 | $2,375 | 12.9% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 21 | 21 | $17,451 | $1,843 | 10.6% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 22 | 22 | $12,254 | $1,812 | 14.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 53 | 57 | $4,621 | $1,521 | 32.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 16 | 16 | $3,402 | $1,494 | 43.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 16 | 16 | $4,432 | $1,475 | 33.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 34 | 34 | $5,950 | $1,418 | 23.8% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 18 | 18 | $3,600 | $1,127 | 31.3% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 16 | 21 | $1,773 | $780.86 | 44.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 161 | 161 | $25,438 | $11,697 | 46.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 201 | 235 | $18,810 | $9,180 | 48.8% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 60 | 60 | $47,940 | $8,024 | 16.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 85 | 98 | $12,348 | $5,452 | 44.2% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 42 | 42 | $37,632 | $4,977 | 13.2% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 25 | 25 | $34,550 | $4,782 | 13.8% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 25 | 25 | $21,650 | $4,404 | 20.3% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 45 | 45 | $26,460 | $3,859 | 14.6% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 35 | 35 | $23,590 | $3,372 | 14.3% |
| 91010 | Study of esophagus to assess movement | Facility | 2022 | 12 | 12 | $4,056 | $604.26 | 14.9% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2021 | 91 | 91 | $78,806 | $16,216 | 20.6% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 243 | 320 | $25,600 | $12,653 | 49.4% |
About Dr. Balbir Minhas, MD
Dr. Balbir Minhas, MD is a Gastroenterology healthcare provider based in Columbia, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1033158779.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Balbir Minhas, MD has received a total of $33,515 in payments from pharmaceutical and medical device companies, with $159.95 received in 2023. These payments were reported across 160 transactions from 23 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($28,900).
As a Medicare-enrolled provider, Minhas has provided services to 2,479 Medicare beneficiaries, totaling 2,695 services with total Medicare billing of $199,562. Data is available for 4 years (2020–2023), covering 41 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location Columbia, SC
- Active Since 06/06/2006
- Last Updated 01/30/2023
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1033158779
Products in Payments
- LINZESS (Drug) $28,540
- VIBERZI (Drug) $3,204
- XIFAXAN (Drug) $312.42
- MAVYRET (Drug) $205.61
- LINX (Device) $154.06
- AMJEVITA (Biological) $119.96
- Barrx (Device) $105.40
- Mavyret (Drug) $68.70
- DIFICID (Drug) $67.80
- MOTOFEN (Drug) $62.91
- GI GENIUS (Device) $53.99
- CREON (Drug) $53.68
- MOTEGRITY (Drug) $49.82
- Dexilant (Drug) $49.61
- Trulance (Drug) $41.54
- CLENPIQ (Drug) $35.71
- Aemcolo (Drug) $28.30
- Cook Medical Hemospray (Device) $22.22
- Amitiza (Drug) $22.05
- GATTEX (Drug) $21.93
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Columbia
Rudrajit Rai, Md, MD
Gastroenterology — Payments: $345,636
Dr. Joseph Meserve, M.d, M.D
Gastroenterology — Payments: $86,610
Kenneth Vega, Md, MD
Gastroenterology — Payments: $60,525
Bradley Anderson, Md, MD
Gastroenterology — Payments: $57,839
Dr. Robert Mcclure, Md, MD
Gastroenterology — Payments: $53,900
Dr. Michael Williams, Md, MD
Gastroenterology — Payments: $48,728